Cargando…

Opportunities and Challenges for Decentralized Clinical Trials: European Regulators’ Perspective

Decentralized clinical trials (DCTs) have the potential to improve accessibility, diversity, and retention in clinical trials by moving trial activities to participants’ homes and local surroundings. In this study, we conducted semi‐structured interviews with 20 European regulators to identify regul...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Jong, Amos J., van Rijssel, Tessa I., Zuidgeest, Mira G. P., van Thiel, Ghislaine J. M. W., Askin, Scott, Fons‐Martínez, Jaime, De Smedt, Tim, de Boer, Anthonius, Santa‐Ana‐Tellez, Yared, Gardarsdottir, Helga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540149/ https://www.ncbi.nlm.nih.gov/pubmed/35488483 http://dx.doi.org/10.1002/cpt.2628

Ejemplares similares

COVID‐19 and the Emerging Regulatory Guidance for Ongoing Clinical Trials in the European Union
por: de Jong, Amos Jochanan, et al.
Publicado: (2021)

Which decentralised trial activities are reported in clinical trial protocols of drug trials initiated in 2019–2020? A cross-sectional study in ClinicalTrials.gov
por: de Jong, Amos J, et al.
Publicado: (2022)

A cross-sectional survey on the early impact of COVID-19 on the uptake of decentralised trial methods in the conduct of clinical trials
por: Suman, Arnela, et al.
Publicado: (2022)

Quality of reporting of drug exposure in pharmacoepidemiological studies
por: Hempenius, Mirjam, et al.
Publicado: (2020)

Amiodarone use and the risk of acute pancreatitis: Influence of different exposure definitions
por: Hempenius, Mirjam, et al.
Publicado: (2019)

Drug exposure misclassification in pharmacoepidemiology: Sources and relative impact
por: Hempenius, Mirjam, et al.
Publicado: (2021)

Risk of major bleeding among users of direct oral anticoagulants combined with interacting drugs: A population‐based nested case–control study
por: Zhang, Yumao, et al.
Publicado: (2020)

Impact of anticoagulant exposure misclassification on the bleeding risk of direct oral anticoagulants
por: Hempenius, Mirjam, et al.
Publicado: (2021)

Primary nonadherence to drugs prescribed by general practitioners: A Dutch database study
por: Hempenius, Mirjam, et al.
Publicado: (2022)

Stakeholders’ views on the ethical challenges of pragmatic trials investigating pharmaceutical drugs
por: Kalkman, Shona, et al.
Publicado: (2016)

Opportunities and counterintuitive challenges for decentralized clinical trials to broaden participant inclusion
por: Goodson, Noah, et al.
Publicado: (2022)

Phase IV non-inferiority trials and additional claims of benefit
por: Bernabe, Rosemarie DLC, et al.
Publicado: (2013)

Opportunities for Decentralization in a Pandemic Year: What Does Budget Analysis Show?
por: Zubarevich, N. V.
Publicado: (2021)

Enabling appropriate use of antibiotics: review of European Union procedures of harmonising product information, 2007 to 2020
por: Opalska, Aleksandra, et al.
Publicado: (2020)

The influence of the European paediatric regulation on marketing authorisation of orphan drugs for children
por: Kreeftmeijer-Vegter, Annemarie Rosan, et al.
Publicado: (2014)

New Opportunities and Cautionary Insights about Decentralizing and Deglobalizing Clinical Trials During the Great Lockdown
por: Dunlap, Denise, et al.
Publicado: (2020)

In silico assessment of household level closed water cycles: Towards extreme decentralization
por: Van de Walle, Arjen, et al.
Publicado: (2022)

Demographics in the 2020s—Longevity as a challenge for pharmaceutical drug development, prescribing, dispensing, patient care and quality of life
por: Stegemann, Sven, et al.
Publicado: (2020)

Decentralized project management concept for schedule-critical space projects
por: Campos, Jaime, et al.
Publicado: (2021)

Empowering clinical research in a decentralized world
por: De Brouwer, Walter, et al.
Publicado: (2021)

Decentralized Clinical Trials: The Future of Medical Product Development?∗
por: Van Norman, Gail A.
Publicado: (2021)

SSH-DAuth: secret sharing based decentralized OAuth using decentralized identifier
por: Krishna, Danda Prudhvi, et al.
Publicado: (2023)

The politics of decentralization : forests, power, and people /
Publicado: (2005)

Swarm learning for decentralized artificial intelligence in cancer histopathology
por: Saldanha, Oliver Lester, et al.
Publicado: (2022)

Cost Effectiveness of New Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation in Two Different European Healthcare Settings
por: Verhoef, Talitha I., et al.
Publicado: (2014)

Opportunities and considerations for the design of decentralized delivery of antiretroviral therapy for female sex workers living with HIV in South Africa
por: Comins, Carly A., et al.
Publicado: (2022)

Environmental Systems and Local Actors: Decentralizing Environmental Policy in Uganda
por: Oosterveer, Peter, et al.
Publicado: (2010)

Decentralized management of laboratory automation
por: Chambers, Don
Publicado: (1994)

Influence of Cardiac Decentralization on Cardioprotection
por: Kingma, John G., et al.
Publicado: (2013)

Explaining Party Positions on Decentralization
por: Toubeau, Simon, et al.
Publicado: (2015)

Swarm learning for decentralized healthcare
por: Becker, Matthias
Publicado: (2022)

2514: Governance for a decentralized informatics academic environment
por: Fogg, Thomas, et al.
Publicado: (2018)

Type and Extent of Information on (Potentially Critical) Quality Attributes Described in European Public Assessment Reports for Adalimumab Biosimilars
por: Alsamil, Ali M., et al.
Publicado: (2021)

Ambulatory health service users' experience of waiting time and expenditure and factors associated with the perception of low quality of care in Mexico
por: Sauceda-Valenzuela, Alma Lucila, et al.
Publicado: (2010)

Patients' experiences of the quality of long-term care among the elderly: comparing scores over time
por: Zuidgeest, Marloes, et al.
Publicado: (2012)

Willingness of patients to use unused medication returned to the pharmacy by another patient: a cross-sectional survey
por: Bekker, Charlotte, et al.
Publicado: (2019)

Financing HIV Programming: How Much Should Low- And Middle-Income Countries and their Donors Pay?
por: Galárraga, Omar, et al.
Publicado: (2013)

Decentralize-Change-Recentralize Model of Drug Information Networks in Health Centers: Decentralized Drug Information Services
por: Thomas, Dixon, et al.
Publicado: (2020)

A Decentralized ComBat Algorithm and Applications to Functional Network Connectivity
por: Bostami, Biozid, et al.
Publicado: (2022)

Medical care in clinical genetics: an experience of decentralization in southern Brazil
por: Meneghini, Kevin Francisco Durigon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pkjjsoe7g8u415ebqbicgqpvg7